Compare NVST & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVST | NOVT |
|---|---|---|
| Founded | 2018 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.7B |
| IPO Year | 2019 | 1999 |
| Metric | NVST | NOVT |
|---|---|---|
| Price | $24.23 | $158.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | $26.46 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 2.8M | 325.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.31 | N/A |
| EPS | 0.23 | ★ 0.51 |
| Revenue | ★ $2,566,500,000.00 | $521,290,000.00 |
| Revenue This Year | $6.67 | $8.61 |
| Revenue Next Year | $3.55 | $6.57 |
| P/E Ratio | $104.80 | ★ $94.89 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $16.41 | $98.27 |
| 52 Week High | $30.42 | $149.95 |
| Indicator | NVST | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 36.73 | 75.10 |
| Support Level | $24.21 | $111.73 |
| Resistance Level | $25.41 | N/A |
| Average True Range (ATR) | 1.17 | 6.96 |
| MACD | -0.29 | 2.31 |
| Stochastic Oscillator | 8.47 | 92.92 |
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.